Atenlol Imp B is a synthetic byproduct arising from oxidative modification of the 4-hydroxyphenyl moiety in atenolol, featuring a carboxylic acid substitution at the C-4 position of the benzene ring. This structural alteration introduces a polar, zwitterionic character due to the adjacent amine and carboxylate groups, enhancing hydrophilicity compared to the parent compound. It serves as an HPLC reference standard for quantifying process-related impurities in atenolol drug substance.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1044265 โ | 25 mg | USD 784.00 |
C1=CC(=CC=C1CC(=O)N)OCC(CO)O
InChI=1S/C11H15NO4/c12-11(15)5-8-1-3-10(4-2-8)16-7-9(14)6-13/h1-4,9,13-14H,5-7H2,(H2,12,15)
CQOQCZLTCMUVMX-UHFFFAOYSA-N